NK Cell Infusion
NK Cell Infusion is a biological therapy with 8 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
3
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
7 of 7 finished
0.0%
0 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors
Phase I of Infusion of Selected Donor NK Cells After Allogeneic Stem Cell Transplantation
NK Cell Infusion for Remission Consolidation in AML: A Phase II Trial
NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents
Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation
Clinical Trials (8)
NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors
Phase I of Infusion of Selected Donor NK Cells After Allogeneic Stem Cell Transplantation
NK Cell Infusion for Remission Consolidation in AML: A Phase II Trial
NK Cells as Consolidation Therapy of Acute Myeloid Leukemia in Children/Adolescents
Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation
Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia
Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG
Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies
All 8 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 8